| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/14/2000 | EP1008656A1 Process for producing lh-rh derivatives |
| 06/14/2000 | EP1007546A1 Molecular mimetics of meningococcal b epitopes |
| 06/14/2000 | EP1007545A2 Cyclopeptide derivatives as adhesion inhibitors |
| 06/14/2000 | EP1007544A1 Serine protease inhibitors |
| 06/14/2000 | EP1007537A1 Receptor protein designated 2f1 |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1007078A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 06/14/2000 | EP1007077A1 Compounds and their combinations for the treatment of influenza infection |
| 06/14/2000 | EP0853612B1 Alpha-hydrazino acid derivatives and method for making same |
| 06/14/2000 | CN1256635A Peptide-coated implants and methods for producing same |
| 06/14/2000 | CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them |
| 06/13/2000 | US6075150 A cell antiproliferative agent |
| 06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
| 06/13/2000 | US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
| 06/13/2000 | US6074650 Membrane anchor/active compound conjugate, its preparation and its uses |
| 06/13/2000 | CA2157196C Inhibitors of herpes viral ribonucleotide reductase |
| 06/13/2000 | CA2137072C Conformationally restrained peptide analogs as antiplatelet agents |
| 06/13/2000 | CA2036398C Hiv protease inhibiting agents |
| 06/13/2000 | CA2019006C Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain |
| 06/13/2000 | CA1341023C Peptide derivatives |
| 06/08/2000 | WO2000033078A1 Porous coatings bearing ligand arrays |
| 06/08/2000 | WO2000032622A1 PURIFICATION OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER VIA CRYSTALLIZATION |
| 06/08/2000 | WO2000032621A1 PROCESS FOR PURIFICATION OF N- [N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL] -L-PHENYLALANINE 1-METHYL ESTER |
| 06/08/2000 | WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3 |
| 06/08/2000 | WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 06/08/2000 | WO2000017228A3 Stereoselective process for enalapril |
| 06/08/2000 | CA2353550A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3 |
| 06/07/2000 | EP1006122A1 Phenethylamine derivatives |
| 06/07/2000 | EP1005484A1 Compounds with growth hormone releasing properties |
| 06/07/2000 | CN1255926A 20(S) camptothecin glycoconjugates |
| 06/07/2000 | CN1255498A Process for prepn. of growth hormone stimulating secretion agent and its intermediate |
| 06/07/2000 | CN1053188C Quinolizinone type compounds |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | US6071895 Polar-substituted hydrocarbons |
| 06/06/2000 | US6071707 Phosphotyrosine mimics and method for identifying and using same |
| 06/06/2000 | US6071538 Oral delivery composition comprising supramolecular complex |
| 06/02/2000 | WO2000031546A1 Antibodies to peptides that target git receptors and related methods |
| 06/02/2000 | WO2000031124A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 06/02/2000 | WO2000031121A1 Recombinant factor viii binding peptides |
| 06/02/2000 | WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | WO2000031119A1 Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof |
| 06/02/2000 | WO2000031118A1 AMORPHOUS N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 06/02/2000 | WO2000031117A1 A METHOD FOR THE PREPARATION OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER FROM IMIDAZOLIDIN-4-ONE INTERMEDIATES |
| 06/02/2000 | CA2351893A1 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 06/02/2000 | CA2351408A1 Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof |
| 06/02/2000 | CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | CA2347700A1 Antibodies to peptides that target git receptors and related methods |
| 05/31/2000 | EP1004583A2 Process and hydantoin intermediates for the synthesis of growth hormone secretagogues |
| 05/31/2000 | EP1004322A2 Technetium-99m labeled peptides for thrombus imaging |
| 05/31/2000 | EP1003787A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 05/31/2000 | EP1003775A2 Hepatitis c inhibitor peptides |
| 05/31/2000 | EP0818462A4 Peptide and a method of obtaining it |
| 05/31/2000 | EP0635016B1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 05/31/2000 | CN1255162A Protease inhibitors |
| 05/30/2000 | US6069232 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 05/30/2000 | US6069130 Prodrugs useful in vivo or invitro for preventing or treating coagulation disorders |
| 05/30/2000 | US6069129 Elastin derived composition and method of using same |
| 05/30/2000 | US6068973 Suppressing transmission of influenza a virus to cell by contacting cell with influenza virus peptide of specific sequence chosen by a computer algorithm |
| 05/30/2000 | US6068972 Screening by contacting microorganisms with organic solvent, determining expression of acr-like efflux pump gene locus, comparing to control, altered expression indicates activation of multiple antibiotic resistance phenotype |
| 05/30/2000 | CA2223360C Cyclic peptide compounds and their production process |
| 05/25/2000 | WO2000029425A1 Physiologically active peptides |
| 05/25/2000 | WO2000029405A1 Method for preparing (2s)-1-[ (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 05/25/2000 | WO2000015605A3 Chiral cyanoamines and methods of preparation |
| 05/25/2000 | WO2000009543A3 Hepatitis c inhibitor tri-peptides |
| 05/25/2000 | CA2348676A1 Method for preparing (2s)-1-¬ (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl| pyrrolidine-2- carboxamide |
| 05/24/2000 | EP1002802A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1002069A1 Peptides containing the motif igd and their use as cell migration modulators |
| 05/24/2000 | EP1001976A2 Peptides having potassium channel opener activity |
| 05/24/2000 | EP1001975A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001974A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001972A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001971A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001969A1 Peptidomimetic derivatives suicidal inhibitors of the hiv proliferation |
| 05/24/2000 | EP1001799A1 Pharmaceutical composition containing peptichemio |
| 05/24/2000 | EP1001764A1 Heterocyclic amide compounds as cell adhesion inhibitors |
| 05/24/2000 | EP0793674B1 Human neutrophil elastase inhibitors |
| 05/24/2000 | EP0720620B1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 05/24/2000 | EP0687270B1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 05/24/2000 | EP0529031B1 Improved inhibitors of thrombin |
| 05/24/2000 | CN1254376A 端粒酶逆转录酶 Telomerase reverse transcriptase |
| 05/24/2000 | CN1254345A Serine protease inhibitors |
| 05/24/2000 | CN1052731C Compounds with growth hormone releasing properties |
| 05/24/2000 | CN1052730C Compounds with growth hormone releasing properties |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066715 Ligands for phosphatase binding assay |
| 05/23/2000 | US6066639 Antitumor agents |
| 05/23/2000 | US6066622 Immunomodulating peptides and methods of use |
| 05/23/2000 | CA2066997C Antimicrobial peptide and antimicrobial agent |
| 05/18/2000 | WO2000027418A2 A method for treating tissue damaged from ischemia |
| 05/18/2000 | CA2350133A1 A method for treating tissue damaged from ischemia |
| 05/17/2000 | EP1000086A1 Alatrofloxacin parenteral compositions |
| 05/17/2000 | EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues |
| 05/17/2000 | EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | EP0620825B1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |